S-8 S-8 EX-FILING FEES 0001425205 IOVANCE BIOTHERAPEUTICS, INC. Fees to be Paid 0001425205 2024-08-07 2024-08-07 0001425205 1 2024-08-07 2024-08-07 iso4217:USD xbrli:pure xbrli:shares
Calculation of Filing Fee Tables |
S-8 |
IOVANCE BIOTHERAPEUTICS, INC. |
Table 1: Newly Registered Securities |
|---|
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
|---|
| 1 | Equity | Common stock, par value $0.000041666 per share | Other | 7,389,374 | $ 7.49 | $ 55,346,411.26 | 0.0001476 | $ 8,169.13 |
Total Offering Amounts: | | $ 55,346,411.26 | | $ 8,169.13 |
Total Fee Offsets: | | | | $ 0.00 |
Net Fee Due: | | | | $ 8,169.13 |
1 | (1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of the Registrant's common stock that becomes issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant's outstanding shares of common stock. (2) Represents 7,389,374 additional shares of common stock reserved for issuance under the Registrant's 2018 Equity Incentive Plan, as amended. (3) Estimated in accordance with Rule 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $7.49, the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Market on August 5, 2024. |
|
|
